RNIV charges account for big chunk of Swiss banks’ capital

Trading exposures that cannot be measured accurately using value-at-risk models make up more than one-third of UBS’s market risk capital charge, and almost as large a share at Credit Suisse.

Risks-not-in-VAR (RNIV) accounted for $329 million of the Swiss bank’s total market risk capital requirement of $878 million (37.5%) as of the second quarter of this year.

Its Swiss rival, Credit Suisse, had an RNIV charge of Sfr402 million, 31.7% of its Sfr1.3 billion total. This is a higher percentage

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: